Renalytix Plc Stock
Stocks
RENX
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
London S.E.
19:35:28 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 5.450 GBX | -2.68% |
|
+1.87% | -7.63% |
| 10-28 | Renalytix Plc Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 10-28 | Earnings Flash (RENX.L) Renalytix plc Reports FY26 Revenue $3.0M | MT |
| Market Cap | 13.34M 11.95M 11.02M 9.97M 18.65M 1.27B 18.95M 131M 52.45M 665M 50.05M 48.98M 2.11B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 16.07M 14.82M 13.41M 25.08M 1.71B 25.49M 177M 70.54M 894M 67.31M 65.88M 2.83B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
81.69% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| RENX | Delayed | |
OTC Markets
| RENXF | Delayed | |
|
Deutsche Boerse AG
| 2O9 | Delayed | |
|
Börse Stuttgart
| 2O9 | Delayed | |
|
Boerse Muenchen
| 2O9 | Real-time |
Last Transcript: Renalytix Plc
| 1 day | -2.68% | ||
| 1 week | +1.87% | ||
| Current month | -10.66% | ||
| 1 month | -11.38% | ||
| 3 months | +105.66% | ||
| 6 months | +202.78% | ||
| Current year | -7.63% |
| 1 week | 5.15 |  | 6.1 |
| 1 month | 5.1 | | 6.3 |
| Current year | 1.6 | | 6.57 |
| 1 year | 1.6 | | 8.4 |
| 3 years | 1.6 | | 74.9 |
| 5 years | 1.6 | | 909.7 |
| 10 years | 1.6 | | 1,220 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 15/03/2018 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 28/05/2024 |
Howard Doran
PSD | President | 65 | 30/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James McCullough
BRD | Director/Board Member | 58 | 15/03/2018 |
| Chairman | 74 | - | |
Fergus Fleming
BRD | Director/Board Member | 59 | 15/03/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/13/26 A | Buy | Founder | 250 | 0.0001% | ||
| 2/13/26 A | Buy | Chief Financial Officer | 500 | 0.0001% | ||
| 2/13/26 A | Buy | Founder | 500 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.68% | +1.87% | -33.94% | -86.38% | 45.01M | |
| +0.71% | +2.18% | +27.18% | +64.39% | 260B | |
| +1.24% | +1.33% | +9.26% | +26.13% | 165B | |
| +1.03% | +4.82% | -17.72% | +73.28% | 154B | |
| +0.61% | -4.09% | -57.72% | -13.79% | 61.49B | |
| +2.90% | +6.83% | +14.90% | +53.04% | 52.9B | |
| +0.70% | +2.83% | -12.22% | -6.48% | 52.84B | |
| -2.35% | -3.19% | +6.52% | +63.75% | 51.46B | |
| -0.18% | +1.91% | +24.20% | +76.27% | 51.16B | |
| +0.67% | +4.94% | +38.77% | +96.14% | 46.85B | |
| Average | +0.20% | +1.67% | -0.08% | +34.64% | 89.58B | |
| Weighted average by Cap. | +0.59% | +1.41% | +6.54% | +50.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 2.05 1.89 1.71 3.2 217.98 3.25 22.57 9 114.08 8.59 8.41 361.31 | 3 2.69 2.48 2.24 4.19 285.68 4.26 29.58 11.8 149.51 11.26 11.02 473.54 |
| Net income | -33.46M -29.97M -27.65M -25.02M -46.78M -3.19B -47.54M -330M -132M -1.67B -126M -123M -5.28B | -20.4M -18.27M -16.86M -15.25M -28.53M -1.94B -28.99M -201M -80.23M -1.02B -76.56M -74.93M -3.22B |
| Net Debt | 3.86M 3.45M 3.19M 2.88M 5.39M 367M 5.48M 38M 15.16M 192M 14.47M 14.16M 609M | 4.6M 4.12M 3.8M 3.44M 6.43M 438M 6.54M 45.35M 18.09M 229M 17.26M 16.9M 726M |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | GBX 5.450 | -2.68% | 595,142 |
| 28/10/26 | GBX 5.600 | -5.88% | 2,985,462 |
| 27/10/26 | GBX 5.950 | 0.00% | 616,207 |
| 26/10/26 | GBX 5.950 | -0.83% | 914,935 |
| 23/10/26 | GBX 6.000 | +3.45% | 2,485,415 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
Select your edition
All financial news and data tailored to specific country editions
